Henry Schein (NASDAQ:HSIC) Issues FY 2024 Earnings Guidance

Henry Schein (NASDAQ:HSICGet Free Report) issued an update on its FY 2024 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 4.740-4.740 for the period, compared to the consensus earnings per share estimate of 4.770. The company issued revenue guidance of $12.7 billion-$12.7 billion, compared to the consensus revenue estimate of $12.8 billion. Henry Schein also updated its Q4 2024 guidance to 1.190-1.190 EPS.

Henry Schein Stock Up 6.1 %

Shares of HSIC stock traded up $4.62 during trading hours on Wednesday, hitting $80.72. 610,562 shares of the company’s stock traded hands, compared to its average volume of 1,010,598. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock’s fifty day simple moving average is $73.07 and its two-hundred day simple moving average is $71.21. Henry Schein has a 12-month low of $63.67 and a 12-month high of $82.63. The stock has a market cap of $10.06 billion, a price-to-earnings ratio of 33.26, a PEG ratio of 2.04 and a beta of 0.89.

Henry Schein (NASDAQ:HSICGet Free Report) last issued its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same period in the previous year, the company earned $1.32 earnings per share. The business’s revenue for the quarter was up .4% compared to the same quarter last year. On average, analysts expect that Henry Schein will post 4.78 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on HSIC shares. Barrington Research reaffirmed an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Mizuho began coverage on Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective for the company. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and raised their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Finally, Jefferies Financial Group increased their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Seven research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $79.30.

View Our Latest Report on Henry Schein

Insider Buying and Selling at Henry Schein

In related news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.14% of the company’s stock.

About Henry Schein

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.